Abstract

In recent years, the peptide immunotherapy using dominant T-cell epitopes has been expected as an effective treatment for allergic diseases such as Japanese cedar pollen allergy. To generate genetically manipulated chickens expressing T-cell epitope peptides of Japanese cedar pollen allergens, we constructed retroviral vector plasmids encoding an expression cassette of seven dominant human T-cell epitopes derived from the Japanese cedar pollen allergens (7crp) fused with the Fc region of immunoglobulin A or G, or chicken lysozyme. Retroviral vectors produced using the plasmids were concentrated by ultracentrifugation and injected into developing chicken embryos. The manipulated embryos were cultured to hatch with 44% hatchability. The eggs produced by the genetically manipulated chickens may be used as an oral drug for Japanese cedar pollen allergy.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.